Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy

被引:31
|
作者
Liu, Zhuang [1 ]
Xiao, Mingming [1 ]
Mo, Yaqi [2 ,3 ]
Wang, Han [1 ]
Han, Yamei [1 ]
Zhao, Xu [1 ]
Yang, Xue [1 ]
Liu, Zhenxing [2 ,3 ]
Xu, Bo [1 ,2 ,3 ]
机构
[1] Tianjin Med Univ, Dept Biochem & Mol Biol, Key Lab Breast Canc Prevent & Therapy, Natl Clin Res Ctr Canc,Minist Educ,Canc Inst & Ho, Tianjin 300060, Peoples R China
[2] Chongqing Univ, Canc Hosp, Chongqing Key Lab Intelligent Oncol Breast Canc, Chongqing 300060, Peoples R China
[3] Chongqing Univ, Sch Med, Chongqing 400030, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Palmitoylation; Palmitoylase; Depalmitoylase; Signal transduction; DNA damage response; S-PALMITOYLATION; DNA-REPAIR; RECEPTOR; DEATH; ACYLTRANSFERASE; RESISTANCE; INHIBITORS; EGFR; PD-1; RAS;
D O I
10.7150/ijbs.72244
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein palmitoylation is an increasingly investigated form of post-translational lipid modification that affects protein localization, accumulation, secretion and function. Recently, emerging findings have revealed that protein palmitoylation is crucial for many tumor-related signaling pathways, such as EGFR, RAS, PD-1/PD-L1 signaling, affecting the occurrence, progression and therapeutic response of tumors. Protein palmitoylation and its modifying enzymes, including palmitoylases and depalmitoylases, are expected to be new targets for effective tumor treatment. Recognizing the significance of palmitoylation modification on protein stability, localization and downstream signal regulation, this review focuses on the regulatory roles of protein palmitoylation and its modifying enzymes in tumor cell signal transduction, aiming to bring new ideas for effective cancer prevention and treatment.
引用
收藏
页码:3447 / 3457
页数:11
相关论文
共 50 条
  • [41] Targeting TGF-β signal transduction for fibrosis and cancer therapy
    Peng, Dandan
    Fu, Minyang
    Wang, Manni
    Wei, Yuquan
    Wei, Xiawei
    MOLECULAR CANCER, 2022, 21 (01)
  • [42] Targeting TGF-β signal transduction for fibrosis and cancer therapy
    Dandan Peng
    Minyang Fu
    Manni Wang
    Yuquan Wei
    Xiawei Wei
    Molecular Cancer, 21
  • [43] PARPs in genome stability and signal transduction: implications for cancer therapy
    Palazzo, Luca
    Ahel, Ivan
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2018, 46 : 1681 - 1695
  • [44] Protein Nanotherapeutics as an Emerging Modality for Cancer Therapy
    Cheng, Liang
    Yang, Liang
    Meng, Fenghua
    Zhong, Zhiyuan
    ADVANCED HEALTHCARE MATERIALS, 2018, 7 (20)
  • [45] Emerging roles of targeted small molecule protein-tyrosine kinase inhibitors in cancer therapy
    Smith, JK
    Mamoon, NM
    Duhé, RJ
    ONCOLOGY RESEARCH, 2004, 14 (4-5) : 175 - 225
  • [46] Biophysical signal transduction in cancer cells: Understanding its role in cancer pathogenesis and treatment
    Huang, XiaoLei
    Yang, XiaoXu
    Sun, Chenchen
    Huang, ShuXia
    Cheng, Min
    Han, Yangyang
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2020, 1874 (02):
  • [47] Molecular targeting of cell death signal transduction pathways in cancer
    Petak, Istvan
    Houghton, Janet A.
    Kopper, Laszlo
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2006, 1 (01) : 113 - 131
  • [48] Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles
    Yang, Zhi
    Huang, Shigao
    Zhao, Lina
    CYTOKINE & GROWTH FACTOR REVIEWS, 2022, 64 : 21 - 32
  • [49] Key cancer cell signal transduction pathways as therapeutic targets
    Bianco, RB
    Melisi, D
    Ciardiello, F
    Tortora, G
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (03) : 290 - 294
  • [50] Targeting cancer cell dependencies on developmental signal transduction pathways
    Lum, Lawrence
    CANCER RESEARCH, 2013, 73